Boston Scientific (BSX)

EBITDA Growth

10.53%

Quarterly · Period ending:

BSX logo

BSX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported10.53%
BSX Quarterly EBITDA YoY % (-56.44% → 10.53%)
High-resolution chart · PNG

BSX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific EBITDA Growth — Quarterly
Period endingEBITDA Growth
10.534%
31.7173%
23.3427%
29.4229%
68.3498%
23.6789%
21.0169%
8.4103%
2.1384%
23.6181%
16.9089%
64.4182%
14.8844%
9.7931%
52.008%
-29.4887%
38.4%
6.305%
-21.327%
476.0274%
161.7801%
73.9796%
32.9832%
-67.8414%
-59.9581%
-51%
-22.6016%
-39.2236%
-23.9234%
34.6801%
21.5415%
29.6875%
76.1236%
4.5775%
40.1662%
11.1969%
347.2222%
16.8724%
623.1884%
570.9091%
-136.8286%
161.2903%
77.5974%
-146.6102%
207.874%
-50.134%
-203.01%
-12.5926%
-66.9271%
326.0606%
-0.3333%
162.9371%
111.1143%
-157.0934%
12.3596%
-258.8889%
-1,156.5749%
-39.7917%
-42.9487%
-29.5039%
-5.4913%
135.4505%
142.7397%
121.3873%
-13.0653%
-1,118.0451%
49.5856%
-1.1429%
-14.2241%
-74.1748%
-3,141.791%
110.8434%
7.907%
17.849%
-114.5652%
-76.1494%
20.4482%
-18.3178%
-8.5487%
220.4152%
-36.8142%
-13.2901%
-5.9813%
-173.7245%
5.0186%
115.7343%
135.6828%
94.0594%
161.165%
52.1277%
5.0926%
-23.7736%
43.0556%
32.3944%
-48.2014%
100.7576%
53.1915%
0%
66.8%
-29.7872%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.